Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
30
OPK Quote, Financials, Valuation and Earnings
Last price:
$1.23
Seasonality move
:
-0.02%
Day range:
$1.21 - $1.27
52-week range:
$1.11 - $2.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.53x
P/B ratio:
0.72x
Volume:
2.1M
Avg. volume:
3.2M
1-year change:
-25.9%
Market cap:
$944.3M
Revenue:
$713.1M
EPS (TTM):
-$0.25
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
$139.8M | -$0.07 | -12.77% | -20.56% | $3.56 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.32% | 75.74% | $104.78 |
|
KIDS
OrthoPediatrics Corp.
|
$61.3M | -$0.29 | 12.23% | -12.09% | $24.00 |
|
NTRB
Nutriband, Inc.
|
$765K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
$1.23 | $3.56 | $944.3M | -- | $0.00 | 0% | 1.53x |
|
ABT
Abbott Laboratories
|
$112.68 | $133.39 | $195.9B | 30.43x | $0.63 | 2.13% | 4.44x |
|
BSX
Boston Scientific Corp.
|
$74.73 | $104.78 | $110.8B | 38.54x | $0.00 | 0% | 5.56x |
|
KIDS
OrthoPediatrics Corp.
|
$16.89 | $24.00 | $423.6M | -- | $0.00 | 0% | 1.73x |
|
NTRB
Nutriband, Inc.
|
$4.11 | $15.00 | $50M | -- | $0.00 | 0% | 20.51x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.28 | $5.50 | $37.8M | -- | $0.00 | 0% | 4.41x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
23.25% | 0.345 | 33.19% | 3.02x |
|
ABT
Abbott Laboratories
|
20.25% | 0.141 | -- | 1.12x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.200 | -- | 0.81x |
|
KIDS
OrthoPediatrics Corp.
|
22.39% | -0.385 | 21.68% | 3.39x |
|
NTRB
Nutriband, Inc.
|
3.31% | 2.122 | 0.32% | 7.07x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
$30.4M | -$53.5M | -10.05% | -13.5% | -35.29% | -$37.8M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
BSX
Boston Scientific Corp.
|
$3.7B | $1B | 8.4% | 12.46% | 19.69% | $1.2B |
|
KIDS
OrthoPediatrics Corp.
|
$40M | -$4.9M | -10.3% | -12.83% | -7.95% | -$3.4M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
OPKO Health, Inc. vs. Competitors
-
Which has Higher Returns OPK or ABT?
Abbott Laboratories has a net margin of 14.26% compared to OPKO Health, Inc.'s net margin of 15.5%. OPKO Health, Inc.'s return on equity of -13.5% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.20.02% $0.03 $1.7B ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About OPK or ABT?
OPKO Health, Inc. has a consensus price target of $3.56, signalling upside risk potential of 189.3%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.38%. Given that OPKO Health, Inc. has higher upside potential than Abbott Laboratories, analysts believe OPKO Health, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 ABTAbbott Laboratories16 7 0 -
Is OPK or ABT More Risky?
OPKO Health, Inc. has a beta of 1.472, which suggesting that the stock is 47.199% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock OPK or ABT?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.13% to investors and pays a quarterly dividend of $0.63 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios OPK or ABT?
OPKO Health, Inc. quarterly revenues are $151.7M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. OPKO Health, Inc.'s net income of $21.6M is lower than Abbott Laboratories's net income of $1.8B. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 30.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.53x versus 4.44x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.53x -- $151.7M $21.6M ABTAbbott Laboratories4.44x 30.43x $11.5B $1.8B
-
Which has Higher Returns OPK or BSX?
Boston Scientific Corp. has a net margin of 14.26% compared to OPKO Health, Inc.'s net margin of 12.68%. OPKO Health, Inc.'s return on equity of -13.5% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.20.02% $0.03 $1.7B BSXBoston Scientific Corp.69.58% $0.45 $35.7B -
What do Analysts Say About OPK or BSX?
OPKO Health, Inc. has a consensus price target of $3.56, signalling upside risk potential of 189.3%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.78 which suggests that it could grow by 42.89%. Given that OPKO Health, Inc. has higher upside potential than Boston Scientific Corp., analysts believe OPKO Health, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 BSXBoston Scientific Corp.25 0 0 -
Is OPK or BSX More Risky?
OPKO Health, Inc. has a beta of 1.472, which suggesting that the stock is 47.199% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock OPK or BSX?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or BSX?
OPKO Health, Inc. quarterly revenues are $151.7M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. OPKO Health, Inc.'s net income of $21.6M is lower than Boston Scientific Corp.'s net income of $670M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 38.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.53x versus 5.56x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.53x -- $151.7M $21.6M BSXBoston Scientific Corp.5.56x 38.54x $5.3B $670M
-
Which has Higher Returns OPK or KIDS?
OrthoPediatrics Corp. has a net margin of 14.26% compared to OPKO Health, Inc.'s net margin of -19.22%. OPKO Health, Inc.'s return on equity of -13.5% beat OrthoPediatrics Corp.'s return on equity of -12.83%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.20.02% $0.03 $1.7B KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M -
What do Analysts Say About OPK or KIDS?
OPKO Health, Inc. has a consensus price target of $3.56, signalling upside risk potential of 189.3%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.00 which suggests that it could grow by 42.1%. Given that OPKO Health, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe OPKO Health, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 KIDSOrthoPediatrics Corp.5 1 0 -
Is OPK or KIDS More Risky?
OPKO Health, Inc. has a beta of 1.472, which suggesting that the stock is 47.199% more volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.122, suggesting its more volatile than the S&P 500 by 12.173%.
-
Which is a Better Dividend Stock OPK or KIDS?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or KIDS?
OPKO Health, Inc. quarterly revenues are $151.7M, which are larger than OrthoPediatrics Corp. quarterly revenues of $61.3M. OPKO Health, Inc.'s net income of $21.6M is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.53x versus 1.73x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.53x -- $151.7M $21.6M KIDSOrthoPediatrics Corp.1.73x -- $61.3M -$11.8M
-
Which has Higher Returns OPK or NTRB?
Nutriband, Inc. has a net margin of 14.26% compared to OPKO Health, Inc.'s net margin of -1118.87%. OPKO Health, Inc.'s return on equity of -13.5% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.20.02% $0.03 $1.7B NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About OPK or NTRB?
OPKO Health, Inc. has a consensus price target of $3.56, signalling upside risk potential of 189.3%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 264.96%. Given that Nutriband, Inc. has higher upside potential than OPKO Health, Inc., analysts believe Nutriband, Inc. is more attractive than OPKO Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 NTRBNutriband, Inc.1 0 0 -
Is OPK or NTRB More Risky?
OPKO Health, Inc. has a beta of 1.472, which suggesting that the stock is 47.199% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.886, suggesting its more volatile than the S&P 500 by 88.601%.
-
Which is a Better Dividend Stock OPK or NTRB?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or NTRB?
OPKO Health, Inc. quarterly revenues are $151.7M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. OPKO Health, Inc.'s net income of $21.6M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.53x versus 20.51x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.53x -- $151.7M $21.6M NTRBNutriband, Inc.20.51x -- $346.1K -$3.9M
-
Which has Higher Returns OPK or PSTV?
Plus Therapeutics, Inc. has a net margin of 14.26% compared to OPKO Health, Inc.'s net margin of -316.61%. OPKO Health, Inc.'s return on equity of -13.5% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.20.02% $0.03 $1.7B PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About OPK or PSTV?
OPKO Health, Inc. has a consensus price target of $3.56, signalling upside risk potential of 189.3%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1898.55%. Given that Plus Therapeutics, Inc. has higher upside potential than OPKO Health, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than OPKO Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is OPK or PSTV More Risky?
OPKO Health, Inc. has a beta of 1.472, which suggesting that the stock is 47.199% more volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock OPK or PSTV?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or PSTV?
OPKO Health, Inc. quarterly revenues are $151.7M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. OPKO Health, Inc.'s net income of $21.6M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.53x versus 4.41x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.53x -- $151.7M $21.6M PSTVPlus Therapeutics, Inc.4.41x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 17
Cooper-Standard Holdings, Inc. [CPS] is down 3.36% over the past day.
Buy
58
TPH alert for Feb 17
Tri Pointe Homes, Inc. [TPH] is down 0.24% over the past day.
Sell
20
IRON alert for Feb 17
Disc Medicine, Inc. [IRON] is up 17.19% over the past day.
